Reactivation of Retinopathy of Prematurity After Bevacizumab Injection
Authors:
- Michael P. BlairMichael P. Blair
- Michael J. ShapiroMSMichael J. Shapiro
- Steven J. LichtensteinSLSteven J. Lichtenstein
- John M. GalassoJGJohn M. Galasso
- Rashmi KapurRKRashmi Kapur
- 1 August 2012
- journal article
- case report
- Published by American Medical Association (AMA) in Archives of Ophthalmology (1950)
- Vol. 130 (8) , 1000-1006
Abstract
Research from JAMA Ophthalmology — Reactivation of Retinopathy of Prematurity After Bevacizumab InjectionKeywords
This publication has 6 references indexed in Scilit:
- Significant Treatment Failure With Intravitreous Bevacizumab for Retinopathy of PrematurityArchives of Ophthalmology (1950), 2012
- Retinopathy of Prematurity in the Time of Bevacizumab: Incorporating the BEAT-ROP Results into Clinical PracticeOphthalmology, 2011
- Efficacy of Intravitreal Bevacizumab for Stage 3+ Retinopathy of PrematurityNew England Journal of Medicine, 2011
- Fluorescein Angiography of Recurrent Retinopathy of Prematurity After Initial Intravitreous Bevacizumab TreatmentArchives of Ophthalmology (1950), 2010
- Antivascular endothelial growth factor for retinopathy of prematurityCurrent Opinion in Pediatrics, 2009
- Pathogenesis of retinopathy of prematurityActa Paediatrica, 2002